Thomas Macmahon and Peter Neupert have joined the board of directors of Labcorp, a leading global life sciences company. The two industry veterans bring decades of experience in healthcare and technology to the board, which will enable Labcorp to accelerate its growth and innovation strategies.
Thomas Macmahon is the former CEO and founder of Laboratory Corporation of America (LabCorp), and he has more than 40 years of experience in the healthcare industry. During his tenure at LabCorp, he transformed the company from a regional laboratory to a global leader in diagnostic testing and clinical research. Macmahon’s deep knowledge of the industry and his expertise in strategic planning, mergers and acquisitions, and financial management will be invaluable to Labcorp as it continues to expand its business.
Peter Neupert is a prominent technology executive who has held senior leadership positions at companies like Microsoft, Drugstore.com, and Accolade. He has also served on the boards of many healthcare and technology companies, including Allscripts, Cerner, and Nuance Communications. Neupert’s experience in digital health and his understanding of the intersection of technology and healthcare will help Labcorp leverage new tools and platforms to improve patient outcomes and reduce costs.
Together, Macmahon and Neupert will bring a wealth of knowledge and expertise to Labcorp’s board. The company has been at the forefront of the fight against COVID-19, providing testing and research services to help combat the pandemic. With Macmahon and Neupert on board, Labcorp will be better positioned to continue its work in the fight against the virus while also advancing its long-term growth and innovation strategies.
“We are thrilled to welcome Thomas Macmahon and Peter Neupert to our board of directors,” said Adam Schechter, chairman and CEO of Labcorp. “Their deep knowledge of the healthcare and technology industries will be invaluable as we continue to innovate and expand our business. We look forward to benefiting from their insights and counsel as we work to improve the health and well-being of people around the world.”
Labcorp’s board of directors now consists of 11 members, including Macmahon and Neupert. The board provides strategic guidance and oversight to the company’s management team, and it plays a critical role in shaping the company’s vision and direction. With the addition of two industry veterans like Macmahon and Neupert, Labcorp is well-positioned to continue its growth and success in the years ahead.
